The blogosphere is alive with the news that a federal court has overturned a patent held by Myriad Genetics for the BRCA1 and BRCA2 breast cancer genes. The company patented the genes in the 1990s and then invented a test to identify some of the mutations, according to the Los Angeles Times blog Booster Shots. "You might be asking yourself how a company could get a patent on a gene, which isn’t a man-made invention.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.